Benuvia Operations, LLC (Benuvia), a global contract development and manufacturing organization, today announced that it has been awarded a five-year contract by the National Institute on Drug Abuse ...

Introduction: the need for advanced monitoring in shake flasks. Shake flasks have been a cornerstone of biotechnological research for nearly a century and remain one of the most c ...

The contract will support R&D of high-quality APIs for substance use disorders and mental health conditions, starting with synthesis and scale-up of psilocybin, which is derived from mushrooms.

The antidepressant properties of psilocybin intermediates in mice are ... similar to plants, for de novo synthesis of complex antiviral lignans. Biosynthetic pathway of limonoids after azadirone ...

Benuvia will initially focus on the synthesis and scale-up of psilocybin, a Schedule I substance under the Controlled Substances Act that was granted Breakthrough Therapy designation by the U.S ...

Synthesis belongs to the latter camp ... Mexico has its fair share of iffy opportunities to procure and use psilocybin, whether they’re illegal, exploitative, or unsafe (or all of the above).

Current medical-grade psilocybin production is inefficient and relies on a complicated multistep synthesis. This study has explored and evaluated psilocin ester prodrugs and psilocin salts as ...

Psilocybin is studied as innovative medication in anxiety, substance abuse and treatment-resistant depression. Animal studies show that psychedelics promote neuronal plasticity by strengthening ...

Some words may be mispronounced. DES MOINES — Psilocybin, the psychoactive compound in “magic mushrooms,” could be administered to help treat post-traumatic stress disorder under a bill ...

Psilocybin is the well-known active ingredient in so-called magic mushrooms, which is converted in the body to psilocin—the compound that ultimately unleashes the psychoactive effect.